Headache
Understanding Headache Disorders
Headache disorders, including migraine and tension-type headaches, are among the most common neurological conditions worldwide. Migraines, in particular, affect millions of individuals and are characterized by recurrent episodes of moderate to severe headache, often accompanied by nausea, vomiting, and sensitivity to light or sound. While the exact mechanisms underlying migraines are complex and multifactorial, they involve disruptions in brainstem activity, altered functional connectivity, and imbalances in the autonomic nervous system.
Chronic migraines are often linked to heightened sympathetic activity ("fight or flight") and reduced parasympathetic activity ("rest and digest"), contributing to the persistence of pain and other symptoms. Addressing this autonomic imbalance is critical for effective headache management.
The Vagus Nerve and Its Role in Headache Regulation
The vagus nerve plays a central role in regulating autonomic balance and modulating pain pathways. It connects the brainstem to multiple organs and influences physiological processes such as inflammation, pain perception, and stress regulation. Dysfunction of vagal activity has been observed in patients with migraines, where reduced parasympathetic tone and heightened sympathetic activity contribute to pain and headache frequency.
By stimulating the vagus nerve, it may be possible to modulate pain pathways, improve autonomic balance, and reduce the frequency and severity of headaches.
Why taVNS Can Improve Headaches
Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive neuromodulation technique that targets the auricular branch of the vagus nerve through electrodes placed on the ear. Unlike invasive vagus nerve stimulation (VNS), which requires surgical implantation, taVNS offers a safer and more accessible alternative.
Mechanisms of Action
taVNS works by activating vagal afferent fibers, which transmit signals to the brainstem and higher brain regions involved in pain modulation, such as the periaqueductal gray (PAG), locus coeruleus, and amygdala. These areas are responsible for autonomic control, pain processing, and emotional regulation. By influencing these neural circuits, taVNS can help reduce pain intensity, improve parasympathetic activity, and modulate inflammatory responses.
Recent Clinical Evidence Supporting taVNS
Functional Connectivity and taVNS (Cao et al., 2021)
A study comparing the effects of 1 Hz and 20 Hz taVNS on patients with migraines found that both frequencies modulated the functional connectivity of the periaqueductal gray (PAG), a key region involved in pain processing. The 20 Hz stimulation showed stronger modulation effects, suggesting that higher frequencies may be more effective for headache management.
Predicting Efficacy with Brain Imaging (Feng et al., 2022)
This study demonstrated that early fractional amplitude of low-frequency fluctuations (fALFF) in specific brain regions could predict the efficacy of taVNS for migraine treatment. Patients with favorable baseline brain activity patterns experienced significant reductions in headache frequency and intensity after taVNS therapy.
Repeated taVNS for Migraine (Huang et al., 2023)
Repeated taVNS sessions were shown to modulate the functional connectivity of key brainstem regions along the vagus nerve pathway in migraine patients. This study provided evidence that taVNS could induce long-term improvements in autonomic regulation and pain processing.
Instant Effects on Amygdala Connectivity (Luo et al., 2020)
A preliminary study explored the immediate effects of continuous taVNS on the functional connectivity of the amygdala in patients with migraines. Results showed that taVNS rapidly reduced hyperactivity in the amygdala, a region associated with pain and emotional processing, leading to decreased headache intensity.
Systematic Review and Meta-Analysis (Management Review, 2023)
A systematic review of auricular transcutaneous neuromodulation and electro-acupuncture for chronic migraines found that taVNS significantly reduced headache frequency and intensity across multiple studies. The review highlighted the potential of taVNS as a first-line therapy for chronic headache disorders.
Altered Brain Network Patterns (Rao et al., 2023)
After taVNS therapy, migraine patients exhibited altered functional brain network patterns, including improved connectivity in pain modulation regions. These changes correlated with reductions in headache severity and improved overall quality of life.
Respiratory-Gated taVNS (Ronald et al., 2017)
Respiratory-gated auricular vagal afferent nerve stimulation (RAVANS), a variant of taVNS, was shown to modulate brainstem activity and connectivity in migraine patients. This technique integrates taVNS with breathing cycles to enhance therapeutic effects.
Frequency-Specific Effects (Sacca et al., 2023)
An fMRI study evaluating different taVNS frequencies found that both low (1 Hz) and high (20 Hz) frequencies modulated brain activity along the central vagus nerve pathway. However, higher frequencies were associated with stronger pain relief and autonomic regulation.
Randomized Controlled Trial (Straube et al., 2015)
A randomized clinical trial demonstrated that taVNS significantly reduced headache days and pain intensity in patients with chronic migraines compared to sham stimulation. The therapy was well-tolerated, with minimal side effects.
Recommended Stimulation Parameters
Based on the reviewed studies, the following stimulation parameters are commonly recommended for taVNS in headache management:
-
Frequency: 1 Hz to 20 Hz (1 Hz often shows stronger effects).
-
Pulse Width: Typically ranges between 200 μs to 300 μs.
-
Duration: 30 minutes per session, administered daily or several times per week.
-
Electrode Placement: Cymba conchae or tragus of the ear.
-
Therapy Duration: Most studies report preventive effects after 4–6 weeks of regular sessions; Some studies report acute effects after 1-2 hours of each session.
Challenges and Future Directions
Standardization of Protocols
Clinical studies vary widely in stimulation settings, making it difficult to establish standardized treatment protocols. Further research is needed to optimize frequency, pulse width, and electrode placement.
Long-Term Efficacy
While taVNS has shown promising short-term effects, data on long-term efficacy and safety are limited. Longitudinal studies are required to evaluate sustained benefits and potential adverse outcomes.
Mechanistic Understanding
Although taVNS has demonstrated efficacy, the precise neural mechanisms underlying its effects remain unclear. Advanced neuroimaging techniques, such as functional MRI, can help elucidate how taVNS modulates pain pathways.
Accessibility and Cost
Despite being non-invasive, access to taVNS devices and trained professionals may be limited in some regions. Efforts should be made to improve affordability and availability of taVNS technology.
Personalized Treatment
Not all patients respond equally to taVNS therapy. Identifying biomarkers, such as baseline brain activity or autonomic measures, could enable personalized treatment approaches and improve outcomes.
Conclusion
Transcutaneous auricular vagus nerve stimulation (taVNS) represents a promising non-invasive therapy for managing headache disorders, particularly migraines. By targeting the vagus nerve, taVNS offers a novel mechanism to restore autonomic balance, modulate pain pathways, and improve functional connectivity in key brain regions. While clinical evidence supports its efficacy, further research is needed to address existing challenges and optimize its use. As advancements in taVNS technology and understanding continue, it may emerge as a transformative tool in headache management.
References:
-
Cao, J., Wang, X., Zhang, Y., & Zhang, Q. (2021). Different modulation effects of 1 Hz and 20 Hz transcutaneous auricular vagus nerve stimulation on the functional connectivity of the periaqueductal gray in patients with migraine. Journal of Translational Medicine, 19(354). https://doi.org/10.1186/s12967-021-03024-9
-
Feng, Z., Luo, M., Zhang, Y., & Rong, P. (2022). Early fractional amplitude of low-frequency fluctuation can predict the efficacy of transcutaneous auricular vagus nerve stimulation treatment for migraine without aura. Frontiers in Molecular Neuroscience, 15(778139). https://doi.org/10.3389/fnmol.2022.778139
-
Huang, J., Liu, X., Zhang, Y., & Rong, P. (2023). The modulation effects of repeated transcutaneous auricular vagus nerve stimulation on the functional connectivity of key brainstem regions along the vagus nerve pathway in migraine patients. Frontiers in Molecular Neuroscience, 16(1151892). https://doi.org/10.3389/fnins.2023.1151892
-
Kampusch, S., Kaniusas, E., & Szeles, J. C. (2015). Modulation of muscle tone and sympathovagal balance in cervical dystonia using percutaneous stimulation of the auricular vagus nerve. Journal of Neurophysiology.
-
Luo, M., Zhang, Y., & Rong, P. (2020). The instant effects of continuous transcutaneous auricular vagus nerve stimulation at acupoints on the functional connectivity of amygdala in migraine without aura: A preliminary study. NeuroImage: Clinical.
-
Management Review Team. (2023). Management of auricular transcutaneous neuromodulation and electro-acupuncture of the vagus nerve for chronic migraine: A systematic review. Frontiers in Neuroscience.
-
Rao, Z., Zhang, Y., & Rong, P. (2023). Altered functional brain network patterns in patients with migraine without aura after transcutaneous auricular vagus nerve stimulation. Scientific Reports, 13(9604). https://doi.org/10.1038/s41598-023-36437-1
-
Ronald, G., Garcia, R., & Zhang, Y. (2017). Modulation of brainstem activity and connectivity by respiratory-gated auricular vagal afferent nerve stimulation (RAVANS) in migraine patients. Journal of Neurophysiology.
-
Sacca, V., Zhang, Y., & Rong, P. (2023). Evaluation of the modulation effects evoked by different transcutaneous auricular vagus nerve stimulation frequencies along the central vagus nerve pathway in migraine: An fMRI study. NeuroImage: Clinical.
-
Straube, A., Eren, O., & Zhang, Y. (2015). Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): A randomized, monocentric clinical trial. Journal of Headache Disorders.
-
Straube, A., Zhang, Q., & Rong, P. (2021). tVNS in the management of headache and pain. Autonomic Neuroscience: Basic and Clinical, 236, 102875. https://doi.org/10.1016/j.autneu.2021.102875
-
Weng, S., et al. (2025). Single-centre, randomized trial of taVNS for chronic migraine. BMJ Open, 15(e092692). https://doi.org/10.1136/bmjopen-2024-092692
-
Zhang, Y., Zhang, Q., & Rong, P. (2021). Transcutaneous auricular vagus nerve stimulation (taVNS) for migraine: An fMRI study. Regional Anesthesia and Pain Medicine, 46, 145–150. https://doi.org/10.1136/rapm-2020-102088
-
Zhang, Y., Zhang, Q., & Rong, P. (2019). Transcutaneous auricular vagus nerve stimulation at 1 Hz modulates locus coeruleus activity and resting-state functional connectivity in patients with migraine: An fMRI study. NeuroImage: Clinical.
Related Posts
什麼是危險過低的 HRV？
兩個人可能醒來時靜息心率相同——比如每分鐘 62 下——身體狀態卻截然不同。其中一個人可能休息得很充分，另一個人卻可能仍受到睡眠不足、高強度訓練、酒精、疾病或壓力的影響。心率呈現的是心臟跳動的速度；HRV 則多提供一層資訊，顯示每次心跳之間的變化。 HRV 測量的是正常心跳之間時間上的微小差異。這些變化會受到呼吸、活動、恢復與自律神經系統等因素影響。 沒有一個 HRV 數值對所有人都算是危險偏低。讀數必須依據所採用的指標、測量方式、你平時的範圍、年齡，以及是否伴隨其他症狀來判讀。 如果你正在問「什麼是危險偏低的 HRV？」，數字本身只是起點。下一步是了解到底測量了什麼，以及該如何判讀結果。 在判定 HRV 危險偏低之前，先確認測量的是什麼 兩個 HRV 數值都可以用毫秒表示，卻未必在回答同一個生理問題。在拿自己的數字與網路上的圖表比較之前，先確認它背後的 HRV 指標、記錄長度、感測器與測量時段。 RMSSD 與 SDNN 不能互換 RMSSD...
Sep 04 2026
什麼是良好的 HRV？
「我的裝置說我的 HRV 是 40 毫秒——這樣算好嗎？」這是許多人在手錶、戒指或健身手環把心率變異度加進早晨儀表板之後，第一個問的問題。誠實的答案是：40 毫秒對你來說可能完全正常，也可能在今天對你來說異常偏低。只有在你了解裝置測量了什麼、你平時的範圍看起來如何，以及測量前後你的身體發生什麼事之後，這個數字才變得有用。這份指南提供一套實用的判斷方式——而不會把 HRV 變成你健康成績的評分。 HRV 實際上測量什麼 心率變異度，或稱 HRV，指的是連續心跳之間時間上的變動，以毫秒為單位。當心率為每分鐘 60 下時，你的心臟通常不會正好每 1,000 毫秒跳一次。一個間期可能是 960 毫秒，下一個是 1,040 毫秒。HRV 就是把這些細微時間差裡的模式加以總結。 這些逐拍變化受到自律神經系統影響，而自律神經系統會因應呼吸、姿勢、身體活動、溫度、情緒、疾病與恢復需求，持續調整心臟功能。因此 HRV 是觀察調節狀態的有用窗口，但它不是直接的「壓力計」，也不能診斷你的神經系統是否健康。它是好幾個系統交互作用後產生的一項訊號。...
Aug 26 2026
配對迷走神經刺激讓中風復健效益維持兩年
配對式迷走神經刺激能讓中風復健成效維持兩年 （invasive vagus nerve stimulation） 引言 為什麼長期效益很重要 一個人是否能再次穩穩地端起杯子，或扣上鈕扣，往往決定了中風後能多獨立地生活。一旦中風進入慢性期，手臂與手部功能的進一步恢復就更加困難。即使復健帶來進步，患者與臨床人員仍想知道這些進步能維持多久。侵入式迷走神經刺激 (invasive vagus nerve stimulation，iVNS) 可以與復健動作同步提供刺激，但它需要手術植入，因此帶來程序負擔與成本等實際障礙。 一篇 2026 年發表於 Neurology 的追蹤研究，檢視了已完成植入式配對刺激治療的慢性缺血性中風患者。研究人員追蹤上肢損傷、活動、參與與生活品質，以判定效益是否持續 2 年；部分參與者也接受了 3 年的評估。核心問題不是治療能否帶來短暫的提升，而是復健成果能否在日常生活中延續。 背景 把刺激與復健配對...
Aug 24 2026
什麼是心率變異性（HRV）？如何正確解讀 HRV
如果你的靜止心率是每分鐘 60 下，哪一種模式聽起來比較健康：一顆像時鐘般精準、每秒跳一次的心臟，還是一顆每次心跳間隔會以毫秒為單位輕微波動的心臟？許多人憑直覺認為心跳越規律越好。但生理學與臨床研究顯示，在正常竇性心律下，健康的心臟並不是節拍器。隨著呼吸、血壓反射與自律神經輸入持續調整心臟的節律，每一次心跳到下一個心跳的間隔會自然波動。這些逐跳波動提供了一扇間接的窗口，讓我們窺見心臟的自律神經調節，包括交感與副交感神經的影響。這種變異稱為心率變異度（heart rate variability），簡稱 HRV。 HRV 較高不一定總是更好，也沒有任何一個「正常」或最佳數值適用於每個人。更有用的做法，是在相似條件下把你的讀值與自己已建立的基準線相比，並著重於長期趨勢，而不是孤立地解讀單一次測量。 什麼是 HRV？它測量什麼？ 心率與心率變異度描述的是同一個節律的兩個不同特徵。心率計算你的心臟每分鐘跳幾下。HRV 測量連續心跳之間的時間變化有多少。 在心電圖（ECG）上，這個時間通常測量連續 R 波之間的間隔—R 波是代表心室活化的明顯尖峰。當只分析正常的竇性心跳時，這些間隔常被稱為 N–N 間隔。HRV 的計算會總結這些間隔如何變化，通常以毫秒為單位。 心率 vs. HRV 指標 它測量什麼...
Aug 20 2026
迷走神經與消化：神經系統如何控制腸胃功能
The same lunch can feel easy one day and leave you uncomfortably full the next. Maybe you slept badly, ate at your desk, rushed...
Jul 31 2026
什麼是腸腦連結？如何改善腸腦連結？
同一餐飯連吃兩天，飯後感受可能完全不同。食物相同，但睡眠、壓力、進食速度、荷爾蒙和腸道節律可能不同。這就是日常的腸腦連結：消化與神經系統不斷互相影響。改善通常不是找一種完美益生菌，而是找出讓循環持續的因素。腸腦連結到底是什麼？消化系統有自己的神經、荷爾蒙、免疫細胞、血液供應與微生物群。大腦接收來自腸道的訊息，也會把訊號傳回去。腸腦軸是連結消化道與大腦的雙向網絡，訊息透過神經、荷爾蒙、免疫訊號、血液循環和腸道微生物產物傳遞。為什麼腸道被稱為「第二大腦」？這個稱呼來自腸神經系統，它能在不等待大腦逐步指揮的情況下，協調腸道運動、液體分泌、血流與局部反射。腸道很獨立，但不代表它會自行思考或產生情緒。「腦腸連結」與「腸腦連結」描述的是同一個雙向系統；前者強調壓力如何影響消化，後者強調腸道訊號向上傳遞。更有用的問題是：現在是什麼因素讓循環持續？腸道與大腦如何溝通？迷走神經迷走神經把大量器官感覺訊息傳向大腦，包括胃部伸展、營養、消化活動和內在狀態，也把訊號傳回消化道，影響部分運動與分泌。但它不是腸腦軸的全部；脊神經、荷爾蒙、免疫路徑與血液中的代謝物也參與其中。腸神經系統腸道內的神經網絡協調食物移動、液體釋放，以及腸道對伸展或化學變化的反應。當訊號變得敏感或協調性下降，普通氣體或壓力也可能感覺更強烈。腸道微生物群腸道微生物分解人體酵素無法完全處理的食物成分，產生可與腸細胞、免疫活動、腸屏障和神經訊號互動的物質。微生物群很重要，但不能解釋每個症狀；許多人體研究仍屬相關性而非因果證明。免疫與發炎訊號腸道含有大量免疫組織，免疫訊使可影響附近神經並透過循環傳遞。這是活躍的研究領域，不代表每個腹脹都等於發炎。壓力如何形成腸腦回饋循環？大腦感受到壓力或危險時，可能改變食慾、胃排空、腸道速度、分泌，以及對內在感覺的敏感度。腸道也會把壓力傳回大腦：抽痛引起擔心，擔心增加緊繃，普通感覺又變得像威脅。壓力相關不代表症狀是想像的；症狀是真實的身體反應。腸腦連結如何影響消化、情緒與睡眠？壓力和睡眠不足可能讓同一餐飯在不同日子引起腹脹、噁心、腹瀉、便秘或抽痛。有人腸道速度變快，有人變慢。情緒低落、焦慮與睡眠中斷也可能互相加強，形成需要同時處理的循環。如何支持腸腦健康？先建立規律進餐、足夠睡眠、適度活動和可持續的飲食模式；觀察哪些食物、藥物、壓力或作息變化與症狀反覆同時出現。慢呼吸、放鬆、散步與減少進食時的匆忙，可能幫助降低腸腦喚醒。不要因為看到網路宣稱就自行嚴格排除食物或大量使用補充品。持續、嚴重、惡化或影響體重與日常功能的症狀，應由醫療專業人員評估。腸腦軸能解釋互相影響，但不能取代對胃腸疾病的診斷。結論腸腦連結是神經、荷爾蒙、免疫、循環和微生物共同構成的雙向系統。迷走神經是重要路徑，卻不是唯一答案。從睡眠、壓力、飲食、活動與醫療評估一起理解症狀，比追逐單一「腸道修復」方法更可靠。
Jul 31 2026
腸腦軸：從日常感受走向健康的核心連結系統
腸腦軸：從日常感受，到健康的核心介面 大多數人都感受過腸腦軸，卻從未替它命名。在公開說話前，你感到胃裡一陣翻騰。在壓力大的一週裡，你失去食慾。連續幾晚睡不好，讓你出現消化不適與一種沉沉的腦霧。這些都不是隨機事件。它們都是身體與大腦溝通的例子。 近年來，這種日常體驗已成為生物醫學研究的核心。2026 年發表於 Chinese Medical Journal 的一篇回顧，將腸腦軸描述為一個複雜、雙向的溝通網絡，整合神經、內分泌、免疫與代謝路徑，以維持體內恆定以及生理與認知的平衡。該文也指出，短鏈脂肪酸、色胺酸代謝物與膽汁酸等微生物代謝物，是影響大腦相關效應的重要媒介。 2025 年發表於 Physiology 的一篇回顧則從疾病角度提出類似觀點。該文主張，腸腦軸的失調不僅與腸胃道狀況相關，也與神經精神、神經退化與神經發育疾病有關，同時也與情緒調節、認知及進食相關狀況的失調有關。換句話說，腸腦軸並不是消化領域中的冷門概念。它正日益被視為全身健康的重要介面。 在 ZenoWell，健康常以長壽的五大支柱來框架：睡眠、壓力調節、營養、活動與連結。連結不僅指我們與自己或與他人的關係。它也包括身體與大腦彼此持續對話的方式。腸腦軸正位於這層關係的核心。它是內部連結如何形塑能量、情緒、韌性與日常功能最清楚的例子之一。 本文說明什麼是腸腦軸、它如何運作、為什麼它可能對壓力、情緒、認知、睡眠與消化很重要，以及如何在日常生活中支持它。有一條界線必須從一開始就說清楚：支持腸腦軸並不等同於治療消化系統疾病、神經系統疾病或心理健康障礙。持續存在的症狀仍需要適當的醫療或心理健康評估。 什麼是腸腦軸？ 腸腦軸是消化道與大腦之間的雙向溝通系統。它讓腸道能把訊息傳給大腦，也讓大腦能把訊號傳回腸道。這套系統涉及的遠不只是消化。它包括腸神經系統、迷走神經、腸道微生物組、內分泌系統、免疫系統，以及各式各樣的神經傳導物質與代謝物。 這就是為什麼人們經常在日常生活中體驗到腸腦軸，卻不需要用科學術語來思考。直覺、焦慮時的反胃、壓力下的食慾變化，以及身體勞累時那種思緒沉重的感覺，都是這種雙向溝通的例子。腸道不只是被動的消化管道。大腦也不只是孤立的指揮中心。它們持續在對話。 腸腦軸如何運作？ 腸腦軸透過數條彼此重疊的路徑運作。這些路徑包括神經、內分泌、免疫與代謝。沒有任何單一路徑能解釋整個系統，而這正是腸腦軸如此重要的原因。它串連了不同層次的生理機能，而不是只依賴單一機制。 腸神經系統 這套網絡的其中一部分是腸神經系統，常被稱為腸道的第二個大腦。它是嵌入消化道管壁中的密集神經網絡。它協助協調腸道蠕動、分泌、血流與局部反射。它能在局部完成數量驚人的這類工作，但它也與中樞神經系統溝通。這就是為什麼在壓力、焦慮或放鬆時，消化能如此迅速改變的原因之一。 迷走神經 另一部分是迷走神經，它負責把來自腸道與其他器官的感覺訊息傳到大腦，並協助把調節訊號往下送回。迷走神經不是一條單向的纜線。它是一條混合神經，而它大部分的纖維是傳入纖維，意思是它們把訊息從身體往上送往大腦。這些傳入纖維把關於牽張、營養素、發炎狀態、微生物代謝物，以及血清素相關訊號等源自腸道的分子訊息，傳遞到腦幹，特別是孤束核。訊息從那裡被整合進涉及自律調節、內感受、情緒、壓力反應與行為狀態等更廣泛的網絡之中。換句話說，大腦不斷接收關於身體內部狀況的最新資訊，而迷走神經正是這些資訊送達的主要管道之一。...
Jul 16 2026
迷走神經與腸易激症候群：腸腦連結代表什麼
如果你有 IBS，症狀未必只跟著你吃了什麼走。腹痛、腹脹、便祕、腹瀉、急迫感，以及壓力誘發的發作，也可能隨著睡眠不佳、旅行或對上廁所的焦慮而變化。這也是為什麼迷走神經與 IBS 經常被放在一起討論：迷走神經是腸腦軸的主要路徑之一，但 IBS 並非單由某一條神經造成。 迷走神經與 IBS 有什麼關係？ 迷走神經是腸腦軸的主要路徑之一，這也是它會在 IBS 相關討論中出現的原因。它有助於協調腸道蠕動、消化反射、壓力後恢復、免疫訊號，以及身體轉向「休息與消化」的狀態。 UCLA Health 將迷走神經描述為這條腸腦路徑的核心部分，其影響超出消化，還延伸到情緒、心率與免疫反應。 IBS 不只是「我吃了什麼？」的問題。食物可以誘發症狀，但在睡眠不足後匆匆吃下的午餐，可能與心情較平穩那天吃的同一餐感覺不同。迷走路徑可能參與腸道蠕動、腸道敏感度與壓力後恢復。同時，IBS 也可能涉及腸道菌相變化、免疫活動、飲食、荷爾蒙、藥物、睡眠與個人誘發因子。 IBS 是腸腦互動問題 大腸激躁症通常定義為與排便習慣改變相關的復發性腹痛。 American College of...
Jul 03 2026
